Biotech firm’s Belgian deal to create dozens of new jobs in San Antonio
Jun 09, 2016
San Antonio is gaining more scientific firepower from afar, lured here in large part by the city’s upside potential. The latest recruit is Dr. Larry Schlesinger, who is convinced the Alamo City is poised to become a far more significant player in the bioscience arena.
Last week, I reported that Texas Biomedical Research Institute had named Schlesinger as its new president and CEO. Schlesinger, who comes from Ohio State University, where he has chaired the Department of Microbial Infection and Immunity and served as director of the Center for Microbial Interface Biology, will start his new job in May.
I reached out to Schlesinger about the decision to come to Texas Biomed and about San Antonio’s ascent in the bioscience sector.
“I got to know more about the institute and the impactful research that’s been going on there for a very long time,” he told me. “I got to know the people and talked to the scientists. I’ve seen the commitment from leadership — particularly the board of trustees.”
But it’s San Antonio’s collaborative environment that caught his attention — and which could propel the city onto a more prominent stage.
“There are a number of very collaborative institutions in San Antonio. That was apparent to me from afar,” Schlesinger said. “Right now, what makes Boston, for example, so powerful is its ability to have institutions working together. That’s happening in San Antonio. There are a lot of motivated people. Leaders are on board.”